| Dasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Cancer Receiving FOLFOX Chemotherapy With or Without Bevacizumab (NCT04164069) | Anne Noonan | 2020-09-02 |
| The Role of Vitamin D in Predicting Response to Neoadjuvant Therapy in Patients With Rectal Cancer (NCT04857203) | Istanbul Training and Research Hospital | 2020-09-01 |
| Encorafenib, Binimetinib, and Nivolumab in Treating Microsatellite Stable BRAF V600E Metastatic Colorectal Cancer (NCT04044430) | University of California, San Francisco | 2020-08-31 |
| Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer (NCT03154190) | Stanford University | 2017-08-08 |
| Low Glycemic Load Diet in Patients With Stage I-III Colon Cancer (NCT02129218) | Case Comprehensive Cancer Center | 2015-02-16 |
| Laparoscopic Surgery or Robotic-Assisted Laparoscopic Surgery in Treating Patients With Rectal Cancer That Can Be Removed By Surgery (NCT01196000) | City of Hope Medical Center | 2011-12-01 |
| Vaccine Therapy in Treating Patients With Colorectal, Stomach, or Pancreatic Cancer (NCT01191684) | City of Hope Medical Center | 2011-10-01 |
| Altered Chemotherapy Sequencing During Neoadjuvant Therapy for Patients With Stage II or III Rectal Adenocarcinoma (NCT01302613) | University of Texas Southwestern Medical Center | 2011-03-01 |
| RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors (NCT01158274) | National Cancer Institute (NCI) | 2010-06-01 |
| Pertuzumab and Cetuximab in Treating Patients With Previously Treated Locally Advanced or Metastatic Colorectal Cancer (NCT00551421) | National Cancer Institute (NCI) | 2007-10-01 |
| Resveratrol in Treating Patients With Colorectal Cancer That Can Be Removed By Surgery (NCT00433576) | National Cancer Institute (NCI) | 2006-12-01 |
| Postoperative Chemotherapy With or Without Bevacizumab for Patients With Stage II or III Rectal Cancer (NCT00303628) | ECOG-ACRIN Cancer Research Group | 2006-05-11 |
| Suberoylanilide Hydroxamic Acid, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Progressive Metastatic or Unresectable Colorectal Cancer or Other Solid Tumors (NCT00138177) | National Cancer Institute (NCI) | 2005-07-01 |
| Sorafenib, Cetuximab, and Irinotecan in Treating Patients With Advanced or Metastatic Colorectal Cancer (NCT00134069) | National Cancer Institute (NCI) | 2005-06-01 |
| Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer (NCT00101348) | National Cancer Institute (NCI) | 2005-01-01 |
| EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer (NCT00087191) | National Cancer Institute (NCI) | 2004-05-01 |
| Combination Chemotherapy and Bevacizumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Colorectal Cancer (NCT00070122) | National Cancer Institute (NCI) | 2004-04-01 |
| Bevacizumab, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer (NCT00052559) | National Cancer Institute (NCI) | 2002-08-01 |
| Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer (NCT00028496) | National Cancer Institute (NCI) | 2001-11-01 |
| Combination Chemotherapy With or Without Bevacizumab Compared With Bevacizumab Alone in Treating Patients With Advanced or Metastatic Colorectal Cancer That Has Been Previously Treated (NCT00025337) | National Cancer Institute (NCI) | 2001-09-01 |
| Oxaliplatin, Fluorouracil, and External-Beam Radiation Therapy Followed by Surgery in Treating Patients With Locally Advanced Cancer of the Rectum (NCT00006094) | National Cancer Institute (NCI) | 2000-07-01 |
| SU5416 and Irinotecan in Treating Patients With Advanced Colorectal Cancer (NCT00005818) | National Cancer Institute (NCI) | 2000-03-01 |
| Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu (NCT00004074) | National Cancer Institute (NCI) | 1999-08-01 |
| Vaccine Therapy in Treating Patients With Colon, Pancreatic, or Lung Cancer (NCT00019006) | National Cancer Institute (NCI) | 1995-03-01 |